Top 50 Medical Startup Investors in Asia in October 2023
Top 50 Medical Startup Investors in Asia in October 2023
| Investor | Medical Asia investments |
|---|---|
| Sequoia Capital China | 26 |
| BioVenture | 19 |
| Qiming Venture Partners | 19 |
| Legend Capital | 17 |
| Puhua Capital | 16 |
| Marathon Venture Partners | 14 |
| Med-Fine Capital | 13 |
| Mitsubishi UFJ Capital | 13 |
| Legend Star | 13 |
| IDG Capital | 12 |
| Northern Light Venture Capital | 12 |
| Frees Fund | 12 |
| Highlight Capital | 12 |
| Lilly Asia Ventures | 11 |
| Prox Ventures | 11 |
| Cowin Venture | 11 |
| Keio Innovation Initiative | 10 |
| Share Capital | 10 |
| Cowin Capital | 9 |
| Trustbridge Partners | 9 |
| SMBC Venture Capital | 9 |
| Hillhouse Capital Group | 9 |
| Gaorong Capital | 9 |
| BioTrack Capital | 9 |
| Cenova | 9 |
| Taiyu Investment | 8 |
| Haibang Capital | 8 |
| Dalton Venture | 8 |
| CDH Investments | 7 |
| Oriental Fortune Capital | 7 |
| DT Capital Partners | 7 |
| Nissay Capital | 7 |
| LYFE Capital | 7 |
| Volcanics Venture | 7 |
| Ping An Ventures | 7 |
| Sherpa Venture Capital | 7 |
| SBCVC | 7 |
| ZSVC | 7 |
| Huagai Capital | 7 |
| Long Hill Capital | 7 |
| ANRI | 7 |
| SBI Investment | 6 |
| Addor Capital | 6 |
| CASH Capital | 6 |
| Co-Stone Venture Capital | 6 |
| OrbiMed | 6 |
| Seeds Capital | 6 |
| Tiantu Capital | 6 |
| Golden Gate Ventures | 6 |
| Lapam Capital | 6 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
We help founders build enduring companies.
Show more...Investment focus
- Health Care, Biotechnology, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Australia
Portfolio highlights
- FUE Bioscience — FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.
- Life Wilderness — Life Wilderness reimagines human-computer interaction and is linked to the transportation and travel industries.
- Xintu Heterogeneous — Xintu Heterogeneous offers data storage solutions for heterogeneous computing.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- China, United States, Taiwan
Portfolio highlights
- Xiguang Bio — Xiguang Bio focuses on the production of diagnostic reagents and provides chemiluminescent raw materials and overall system technology solutions.
- Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
- Panomic Biomedical Technology — Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolitepreprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Atantares — We are a development stage startup enabling the next generation of precision medicine by fusing biochip and AI technologies.
- Saints Sages Medical — Saints Sages Medical is engaged in the production and sales of minimally invasive surgical medical devices. They have several energy device products that are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery, and other departments. Saints Sages closely monitors clinical needs and develops moreinnovative minimally invasive surgical devices to serve global patients, relying on a professional research and development team and years of the clinical transformation experience.
- Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
- Saige Research — Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control. The company provides a deep learning vision inspection platform optimized for the manufacturing industry to solve inspectors' difficulties and increase work efficiency; its technology provides power detection, speed detection, wideversatility, and development convenience.
- Ligatech Bioscience — Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services.
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, United Kingdom, United States
Portfolio highlights
- Zozen — Zhuzheng Robotics is a medical robot manufacturer and developer specializing in minimally invasive spinal surgery. It specializes in researching new, intelligent, high-end medical devices with independent intellectual property rights, researching and developing products related to minimally invasive spinal surgery, and providing related services.
- Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
- Zhejiang Tianneng New Material — Zhejiang Tianneng New Material manufactures batteries as well as recycles, removes, and re-uses old lithium batteries.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
- Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
- Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
- Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
- Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series B, Series A
- Japan, United States, China
Portfolio highlights
- LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
- CADDi — CADDi is an online ordering platform for manufacturing industry.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Angel, Seed
- China, United States, France
Portfolio highlights
- CoJourney — CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
- Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.
- China Reserve National Energy — China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more...Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Infinimos — Infinimos is a Cosmos ecological liquid staking derivatives platform that aims to build a decentralized and democratized ecosystem capable of maximizing staking rewards while retaining liquidity.
- Xbotspace — Xbotspace is the generative AI middleware startup investigates the implementation and deployment of huge language models.
- Biotyx Medical — Biotyx Medical manufactures and sells iron-based biodegradable vascular materials and stents.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Health Care, Medical, Internet
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
- Zhonghui Laser — Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.
- Kangpu Biopharmaceuticals, Ltd. — Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more...Investment focus
- Artificial Intelligence, E-Commerce, Health Care
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
- Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Series C
- China, United States, Portugal
Portfolio highlights
- Etana — PT Etana Biotechnologies Indonesia (Etana) is an emerging producer of high-quality, affordable and innovative biopharmaceuticals to treat a range of metabolic, autoimmune and other major life-threatening diseases, including cancer. Nathan Tirtana. Legend Capital. UOB Venture Management. Innovent Bio
- Hongyixin — Hongyixin is an automotive electronic chip developer.
- Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Akura Medical — Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots.
- Precede Biosciences — Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. Discover how we are helping create a world where medicine is developed more successfully, and every diagnosis is precise and minimally invasive.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- VacV Biotech — VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety andefficiency and can be administered by intravenous injection.
- HROCT LITT Medtech — HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging.The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Angel
- China, United States, Canada
Portfolio highlights
- Makino micro — Makino Micro is a high-tech enterprise dedicated to the research and development of 4D high-precision imaging radar.
- Yimai Silicon — Yimai Silicon is a professional R&D and mass production manufacturer of advanced packaging substrate technology.
- Gongyan Tuoxin — Gongyan Tuoxin is an optoelectronic chip design and development company that focuses on designs and supplies for high-speed optical communications and networking applications, analog and mixed-signal chips
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
- Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more...Investment focus
- Manufacturing, Health Care, Software
- Series A, Series B, Series C
- China, Hong Kong, United States
Portfolio highlights
- SIRUN — SIRUN is a provider and operator of Internet of Vehicles system services, alongside a manufacturer of passenger and commercial vehicles.
- Anpaixin — Anpaixin manufactures thin-film lithium niobite photonic circuits and optical engines.
- Xungene Therapeutics — Xunjing Biotech creates RNA-targeting small molecule medicines. The company's goal is to create RNA-targeting small molecule therapeutics that target uncommon disorders and malignancies. It employs RNA structure detection and artificial intelligence technology with its own intellectual property rights to design, screen, and evaluate smallmolecule drugs, shorten the R&D cycle in a more efficient and smarter manner, improve development efficiency, and promote faster drug marketing.
Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.
Show more...Investment focus
- Health Care, Education, Medical
- Series A, Series B, Series C
- China, United States, United Kingdom
Portfolio highlights
- G7 — G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).
- Future — Get a dedicated coach, personalized training plan and unlimited workouts.
- Hystar — Hystar is a high tech company specializing in advanced PEM electrolysers for large scale green hydrogen production, that is 100% sustainable.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Health Care, Information Technology, Software
- Funding Round, Series A, Series B
- Japan, United States, Mexico
Portfolio highlights
- Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
- Luup — Luup is an Internet Company.
- Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, India
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
- Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.
Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.
Show more...Investment focus
- Software, E-Commerce, Information Technology
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- MKSEMI — MKSEMI is a low-power ultra-wideband (UWB) company, provides a complete high precision location solution for device OEMs and ODMs.
- Cholesgen — Cholesgen is a biopharmaceutical company dedicated to developing original innovative drugs. The company focuses on new disease targets based on biochemistry, disease biology, medicinal chemistry, and clinical translational medicine.
- Lattice Microelectronics — Lattice Microelectronics promote the design and development, module manufacturing and vehicle application of power semiconductors.
BioTrack Capital is a China-based investment firm.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
- Qitan Technology — Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenientinstrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more...Investment focus
- Health Care, Medical, Pharmaceutical
- Series B, Series A, Series C
- China, Singapore, United States
Portfolio highlights
- Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
- Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
- Hunan Yiyi Pharmaceutical Technology — Hunan Yiyi Pharmaceutical Technology
Taiyu Investment is an investment firm.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Angel
- China
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
- Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Angel, Series B
- China
Portfolio highlights
- Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
- Zhongzhiwei Technology — Zhongzhiwei Technology is a new generation of artificial intelligence + machine learning-driven network security collaborative operation solution provider
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
- Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Frebang — Fulibang is a novel material R&D company. Concentrate on high-end functional nanomaterial research and development, manufacture, and sales. The main products are nanofiber-based particle purification materials, antibacterial air purification materials, electrostatic melt-blown fiber filter materials with high efficiency and low resistance, gaspollutant catalytic decomposition materials, and flexible ceramic nanofiber high-temperature-resistant insulation materials.
- Formal-Tech — Formal-Tech is an embedded system software company that specializes in the development, production, and sales of high-safety industrial control software and hardware.
- Jianwang Technology — Jianwang Technology is a high-tech enterprise that specializes in smart energy solutions and is deeply involved in the new energy business. It focuses on the field of power electronics.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more...Investment focus
- Software, Information Technology, E-Commerce
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Microtreat — Microtreat specializes in the research, development, manufacturing, and sale of different high-end industrial application ultra-precision laser equipment, particularly equipment based on infrared, ultraviolet, green light, and ultra-short pulse technology, which is mostly utilized in the field of thin-film solar energy.
- Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
- Pinfeng Medical — Pinfeng Medical is a platform firm that integrates independent research and development, manufacturing, marketing, and service to provide high-quality intelligent testing and precise diagnostic solutions to the local and international in vitro diagnostic industries.
DT Capital Partners is a private equity investment firm that provides growth capital to early and expansion stage companies. They invest in dynamic businesses that have high growth potential, strong management teams, and demonstrated revenue models in both technology-based and traditional industries. DT Capital Partners currently manages overUSD$500 Million in capital across multiple US dollar and RMB funds, and also has a close affiliation with Madrone Capital in the US, the investment entity for members of the Walton family.In addition to funds, the invested company also benefits from their extensive experience in operating capital markets across the country, close relationships with local governments and companies, and synergies with other investment companies.DT Capital Partners was awarded the “Top 10 China's Best Return Venture Capital Institution” in 2016, and the founding partners of Detong Capital, Shao Jun and Tian Lixin. DT Capital Partner was founded in 2006 and is based in Shanghai, China.
Show more...Investment focus
- Health Care, Medical, Software
- Series A, Series B, Series C
- China, United States, South Korea
Portfolio highlights
- Parylene — Parylene is a provider of protective coating application solutions
- CytoNiche — CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
- Next Generation Gene Therapeutics — Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world.NGGT was founded in March 2020by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Health Care, Internet, Medical
- Funding Round, Seed, Series A
- Japan, United States
Portfolio highlights
- Todoker — Todoker is a baggage delivery convenient service providing company.
- LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
- Beer and Tech — Beer and Tech operates a website for the Phalaenopsis or foliage plant HitoHana. Norihisa Morita and Yoshiaki Ito founded it in 2014, with its headquarters in Saitama in Japan.
In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Series C
- China, United States, France
Portfolio highlights
- Noah Medical — Noah Medical is a manufacturer of medical robotic devices used to diagnose and treat patients in a variety of settings. The company's devices perform early diagnoses and treatments in advanced clinical settings, allowing hospitals to treat patients earlier and save lives while leaving only minor scars.
- HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
- Genepoint Biological Technology — Genepoint Biological Technology is a healthcare Company.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
- Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
- Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Ping An Ventures is a professional VC under Ping An Insurance (Group) Company of China, Ltd. with focused interest in start-ups of emerging innovation. It is committed to growing with the partners and driving success by provision of both funds and managerial expertise, resources and a platform."
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Angel
- China, United States, Israel
Portfolio highlights
- Xiaoqule — Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia.Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects localbusinesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.
- Zhangshang Tangyi — Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
- Xgene Pharmaceutical — Xgene Pharmaceutical is a pharmaceutical company.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
- Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
- Danking Pharmaceuticals — Danking Medicine is an innovation-driven drug developer.
Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.
Show more...Investment focus
- Health Care, Software, Information Technology
- Series B, Series A, Series C
- China, United States, Australia
Portfolio highlights
- HaploX Biotechnology — HaploX Biotechnology is a Shenzhen-based genetic sequencing company.
- Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
- Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Health Care, Manufacturing, Medical
- Series A, Series B, Angel
- China, United States
Portfolio highlights
- Evolusia — Evolusia is Justice
- Pin Point — Pin Point is a high-tech company specializing in the research and development of high-precision positioning system products and solutions.
- Yugong Hi-Tech — Yugong Hi-Tech is a battery cell vacuum drying equipment research and development supplier. It focuses on battery drying and is the industry's first non-contact vacuum drying solution. The company offers non-contact drying solutions for cylinders, soft packages, and square shells.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Angel
- China, United States, Hong Kong
Portfolio highlights
- Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
- Leaf Biotech — Leaf Biotech is a research and development, production and sales of green chemical-related materials and series intermediates. The business produces biomass resources. The focus of the research and development is the bio-based polyester material PEF and important intermediates, as well as the creation of green drugs and intermediates for healthcareproducts.
- Dingzhi Biotech — Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Show more...Investment focus
- Medical, Health Care, Training
- Series A, Series B, Angel
- China, United States
Portfolio highlights
- Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
- Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
- Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- YourTrade — YourTrade helps cross-border e-commerce companies to resale rejected goods and backlogged inventory from overseas sales through local sales channels.It also provides services such as collection and inspection of returned items, as well as resale through local sales channels.
- Carnot — LLM, Autonomous Agent
SBI Investment supports the business development and growth of private venture companies through fund investment.
Show more...Investment focus
- Financial Services, Information Technology, Software
- Funding Round, Series B, Series A
- Japan, South Korea, United States
Portfolio highlights
- Vark — ActEvolve develops Blitz Freak, a multi virtual reality game. It began operation in 2017, with its headquarters in Tokyo in Japan.
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more...Investment focus
- Manufacturing, Medical, Electronics
- Series A, Series B, Funding Round
- China, Hong Kong, United States
Portfolio highlights
- Superfuse — Superfuse specializes in R&D and production of high-performance fuse products & new generation Pyrofuse instantaneous breaker products for new energy vehicles, charging piles, wind and solar storage, two-wheeled vehicles, electric ships, data centers.
- Aikeda Bio — Aikeda Bio provides R&D production, sales and technical services. Its products cover coagulation detection systems, specific protein detection systems, reproductive detection systems and immune detection systems
- Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more...Investment focus
- Health Care, Biotechnology, Manufacturing
- Series A, Series B, Series C
- China, United States
Portfolio highlights
- AKA Robotics — AKA Robotics developer special robots, industrial robots, intelligent equipment, and other technologies. It mainly provides professional solutions such as rust removal, cleaning, deicing, testing, spraying, and grinding for industries such as ships, petrochemicals, wind power, offshore platforms, and steel structure bridges.AKA Robotics aims tocompletely free workers from harsh working environments such as high risk and high pollution, help enterprises transform and upgrade, and achieve the goal of green development.
- Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
- Boardstone Intelligence — Boardstone Intelligence is a provider of precision 3D inspection solutions and laboratory analysis solutions.
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Show more...Investment focus
- Manufacturing, Software, Hardware
- Series A, Series B, Series C
- China, United States
Portfolio highlights
- Beiyi Semiconductor — Beiyi Semiconductor Technology is a national high-tech enterprise integrating R&D, production, packaging, testing, marketing and service of power semiconductor devices. Beiyi Semi's main products are IGBT modules and chips and other products, and it has made positive progress in the research of SiC modules.
- Hyasic Semiconductor — Hyasic Semiconductor is a digital power chip designer and digital-analog hybrid IC products supplier company.
- Bynav Technology — Bynav specializes in the development of GNSS high-precision positioning core components, and is committed to providing reliable high-precision positioning in demanding environments. With GNSS signal processing algorithm, RTK algorithm and multi-source fusion algorithm as the core, the company has developed a series of products such as GNSS ASIC,GNSS OEM board and GNSS/INS receiver used in autonomous driving, surveying and mapping, aerospace and industrial control.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Seed, Series A, Funding Round
- Singapore, Hong Kong, United States
Portfolio highlights
- Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
- HydroLeap — Hydroleap reimagines the way the world looks at water. We provide chemical-free, high-performance & modularized technologies to replace conventional processes.
- Zuno Carbon — Zuno provides end-to-end carbon management solutions that helps organizations measure, offset, and reduce emissions by integrating across your business value chain to collect activity data
Tiantu Capital is a venture capital association.
Show more...Investment focus
- Food and Beverage, E-Commerce, Internet
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- BaiTube — BaiTube is a provider of Multi-Channel Network short video services. Its businesses include short videos, live e-commerce, and brand marketing that help users with different needs and easily find interesting and useful videos online.
- Boyin Bio — Boyin Bio is an innovative biomaterial research and development and application enterprise.
- META Pharmaceuticals — META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.
Golden Gate Ventures is a venture capital firm investing across Southeast Asia. Since 2011, the firm has launched four funds, managed US$250M AUM, and invested in 60+ companies in over 7 countries in Asia. The firm focuses on investing in technology companies driven by the rising consumer class in Southeast Asia.
Show more...Investment focus
- FinTech, E-Commerce, Financial Services
- Seed, Series A, Series B
- Singapore, Indonesia, Thailand
Portfolio highlights
- 13o3 — 13o3 is a boutique investment firm specializing in providing tailored solutions to complex and sophisticated business challenges for discerning clientele, mainly high-profile individuals. Launched in 2013 and founded by Asfand Yar Saeed, the company operates under the
- Locofy — Locofy provides a service that converts designs into code. Locofy.ai aims to take away the menial work of engineers without adding complexity i.e. automating 50% or more of the current workflow starting with frontend code, allowing teams to convert their designs to code and an interactive and responsive live prototype (that runs on code), withoutwriting a single line of code.
- Yisheng — Yisheng is a digital service platform for door-to-door car washing.
Lapam Capital is a healthcare-focused venture capital firm.
Show more...Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series B, Series A, Series C
- China, United States
Portfolio highlights
- Deyun Kangrui — Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&D and the production of full-chain single-cell multi-omics technology.
- BridGene Biosciences — BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.
- NeuShen Therapeutics — NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: